Qt Imaging Holdings, INC 8-K filings

QT Imaging announced positive Q1 2025 financial results, including $2.8 million in revenue, a 65% gross margin, and a new manufacturing agreement with Canon Medical Systems Corporation.

QT Imaging Holdings' stock is delisted from Nasdaq and commences trading on the OTCQB Venture Market, while the company grants stock options to its CEO and CFO.

QT Imaging Holdings announces a $500,000 private placement with its Chairman and CEO, aimed at bolstering working capital, following its delisting from Nasdaq.

QT Imaging reports increased revenue and gross margin for 2024, forecasts substantial revenue growth for 2025 and 2026, and highlights strategic partnerships and debt restructuring.

QT Imaging Holdings receives $10.1 million in new funding from Lynrock Lake Master Fund LP to support working capital, retire debt, and terminate the SEPA line with Yorkville.

QT Imaging Holdings will be delisted from the Nasdaq Stock Market and will begin trading on the over-the-counter market after failing to meet minimum market value and share price requirements.

QT Imaging Holdings, Inc. has entered into a sublease agreement with QT Imaging Center for office space in Novato, CA, commencing January 23, 2025.

QT Imaging Holdings has amended its financing agreements with YA II PN, Ltd. and Funicular Funds, LP, modifying debt terms, removing monthly payment obligations, and extending maturity dates.

QT Imaging Holdings, Inc. is facing potential delisting from the Nasdaq due to non-compliance with minimum share price and market value requirements, and is appealing the decision.

QT Imaging and NXC Imaging have amended their distribution agreement, introducing minimum order quantities and extending the term to December 31, 2026.

QT Imaging Holdings reported a significant increase in revenue and gross margin in Q3 2024, driven by sales of its innovative breast imaging technology.

QT Imaging announced its third quarter 2024 financial results, highlighted by $0.9 million in scanner sales revenue and a $2.56 million PIPE investment from its board members.

QT Imaging Holdings, Inc. has received notice from Nasdaq that it will be delisted due to not meeting the minimum market value requirement, and the company plans to appeal the decision.

QT Imaging Holdings has amended its financing agreement with YA II PN, Ltd., extending the maturity date of its promissory note and reducing the floor price for potential share conversions.

QT Imaging Holdings has amended its financing agreement with YA II PN, Ltd., extending the maturity date of its promissory note and modifying payment terms to alleviate immediate financial pressure.

QT Imaging Holdings is obligated to make monthly payments to Yorkville due to a trigger event related to its stock price falling below a specified floor price.

QT Imaging Holdings has received a notice from Nasdaq for failing to meet the minimum Market Value of Publicly Held Securities requirement, adding to existing concerns about its listing status.

QT Imaging Holdings reports a significant increase in revenue and progress in commercialization efforts, highlighted by a distribution agreement with NXC Imaging and a feasibility study agreement with Canon Medical Systems.

QT Imaging announced its second quarter 2024 financial results, highlighted by $1.7 million in revenue and a 51% gross margin, alongside strategic partnerships and expanded distribution.

QT Imaging has entered into a new distribution agreement with NXC Imaging, granting NXC exclusive rights to market and resell QT Imaging's equipment in the U.S. and its territories, replacing a previous sales agent agreement.

QT Imaging Holdings has received a notice from Nasdaq for failing to maintain a minimum share price of $1.00, adding to existing concerns about its market value.

QT Imaging Holdings has lowered the exercise price of its warrants from $11.50 to $2.30 per share due to a prior equity raise.

QT Imaging Holdings has received a notice from Nasdaq for failing to maintain the minimum market value of listed securities, putting its listing status at risk.

QT Imaging announced its first quarter 2024 financial results, highlighting $1.4 million in scanner sales revenue and a 56% gross margin, alongside strategic partnerships and research advancements.

QT Imaging Holdings has entered into a sublease agreement with QT Imaging Center for space and equipment, while also terminating their existing Management Services Agreement.

QT Imaging Holdings has established agreements with QT Imaging Center for data licensing and healthcare services, including clinical trial support and training.

QT Imaging Holdings released an investor presentation detailing its innovative, radiation-free 3D breast imaging technology and its potential to disrupt the medical imaging market.

QT Imaging Holdings, Inc. has entered into a feasibility study agreement with Canon Medical Systems Corporation to evaluate the business, technical, and clinical potential of QT Imaging's ultrasound breast scanner.

QT Imaging Holdings, Inc. has filed an amendment to its initial 8-K report, including audited financial statements for 2022 and 2023, and pro forma combined financials following its business combination.

QT Imaging Holdings has announced the resignation of a Class I director and the appointment of a new director to fill the vacancy, effective March 18 and March 21, 2024, respectively.